Literature DB >> 25600968

Developing cutaneous applications of paromomycin entrapped in stimuli-sensitive block copolymer nanogel dispersions.

Alba Pujol Brugués1, Beatriz Clares Naveros, Ana C Calpena Campmany, Pilar Hernández Pastor, Roser Fisa Saladrigas, Cristina Riera Lizandra.   

Abstract

AIM: A new paromomycin micellar nanogel based on poloxamer 407 was developed. MATERIALS &
METHODS: In vitro release and ex vivo permeation/retention studies were conducted. In vivo tolerance was assayed by transepidermal water loss. Ex vivo cytotoxicity on RAW and VERO cells and antileishmanial activity on Leishmania promastigotes was tested.
RESULTS: The particle size was 9.19 nm (99% loading efficiency) exhibiting Newtonian behavior at 4°C and was pseudoplastic at 25 and 40°C. Drug release followed a Weibull model and the drug remaining in the skin was 31.652 µg/g/cm(2). In vivo tolerance achieved excellent results with negligible cellular toxicity and the best antileishmanial efficiency.
CONCLUSION: The nanogel provided controlled, effective and safe delivery of paromomycin for the treatment of cutaneous leishmaniasis.

Entities:  

Keywords:  cutaneous leishmaniasis; nanogel; paromomycin; poloxamer 407; polymeric micelles

Mesh:

Substances:

Year:  2015        PMID: 25600968     DOI: 10.2217/nnm.14.102

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  10 in total

Review 1.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

2.  Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.

Authors:  Mireia Mallandrich; Francisco Fernández-Campos; Beatriz Clares; Lyda Halbaut; Cristina Alonso; Luisa Coderch; Maria L Garduño-Ramírez; Berenice Andrade; Alfonso Del Pozo; Majella E Lane; Ana C Calpena
Journal:  Pharm Res       Date:  2017-05-24       Impact factor: 4.200

3.  Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani.

Authors:  Sushmita Ghosh; Vinay Kumar; Aditya Verma; Tanya Sharma; Dibyabhaba Pradhan; Angamuthu Selvapandiyan; Poonam Salotra; Ruchi Singh
Journal:  Parasitol Res       Date:  2022-09-03       Impact factor: 2.383

4.  An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.

Authors:  Letícia Martins Dos Reis Lage; José Mário Barichello; Daniela Pagliara Lage; Débora Vasconcelos Costa Mendonça; Ana Maria Ravena Severino Carvalho; Marcella Rezende Rodrigues; Daniel Menezes-Souza; Bruno Mendes Roatt; Ricardo José Alves; Carlos Alberto Pereira Tavares; Eduardo Antonio Ferraz Coelho; Mariana Costa Duarte
Journal:  Parasitol Res       Date:  2016-07-01       Impact factor: 2.289

5.  Ultrasound-Assisted Preparation of Exopolysaccharide/Nystatin Nanoemulsion for Treatment of Vulvovaginal Candidiasis.

Authors:  Ruiteng Song; Fang Yan; Min Cheng; Fakun Dong; Yongqi Lin; Yuzhen Wang; Bo Song
Journal:  Int J Nanomedicine       Date:  2020-03-25

Review 6.  Nanostructured delivery systems with improved leishmanicidal activity: a critical review.

Authors:  Natascia Bruni; Barbara Stella; Leonardo Giraudo; Carlo Della Pepa; Daniela Gastaldi; Franco Dosio
Journal:  Int J Nanomedicine       Date:  2017-07-26

7.  Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis.

Authors:  Diana Berenguer; Lilian Sosa; Magdalena Alcover; Marcella Sessa; Lyda Halbaut; Carme Guillén; Roser Fisa; Ana Cristina Calpena-Campmany; Cristina Riera
Journal:  Pharmaceutics       Date:  2019-11-15       Impact factor: 6.321

8.  Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis.

Authors:  Sandra Milena Leal Pinto; Luis Alexandre Muehlmann; Lucía Liliana Mantilla Ojeda; Angélica María Vera Arias; Martha Viviana Roa Cordero; María de Fátima Menezes Almeida Santos; Ricardo Bentes Azevedo; Patricia Escobar Rivero
Journal:  Infect Chemother       Date:  2021-06

9.  Characterization of a Topically Testable Model of Burn Injury on Human Skin Explants.

Authors:  Olivia Gross-Amat; Marine Guillen; Damien Salmon; Serge Nataf; Céline Auxenfans
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

10.  New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis.

Authors:  Noelia Pérez-González; Nuria Bozal-de Febrer; Ana C Calpena-Campmany; Anna Nardi-Ricart; María J Rodríguez-Lagunas; José A Morales-Molina; José L Soriano-Ruiz; Francisco Fernández-Campos; Beatriz Clares-Naveros
Journal:  Gels       Date:  2021-12-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.